Erin E Gaughan (Erin Gaughan)

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Erin E Gaughan, Tom M Quinn, Andrew Mills, Annya M Bruce, Jean Antonelli, Alison MacKinnon, Vassilios Aslanis, Feng Li, Richard O'Connor, Cecilia Boz, Ross Mills, Philip Emanuel, Matthew Burgess, Giulia Rinaldi, Asta Valanciute, Bethany Mills, Emma Scholefield, Gareth Hardisty, Emily Gwyer Findlay, Richard A Parker, John Norrie, James W Dear, Ahsan R Akram, Oliver Koch, Kate Templeton, David H Dockrell, Timothy S Walsh, Stephen Partridge, Duncan Humphries, Jie Wang-Jairaj, Robert J Slack, Hans Schambye, De Phung, Lise Gravelle, Bertil Lindmark, Manu Shankar-Hari, Nikhil Hirani, Tariq Sethi, Kevin Dhaliwal
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis (DEFINE): A Phase Ib/IIa Randomised Controlled Trial. American journal of respiratory and critical care medicine (2022)
Erin E Gaughan, Tom Quinn, Annya Bruce, Jean Antonelli, Vikki Young, Joanne Mair, Ahsan Akram, Nik Hirani, Oliver Koch, Claire Mackintosh, John Norrie, James W Dear, Kevin Dhaliwal
Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platform. BMJ open 11 (12) (2021)

Erin E Gaughan.css-eqlu8i{font-size:small;padding-left:4px;} (Erin Gaughan)